Michael Williams, MD, ScM, is the Byrd S. Leavell Professor of Medicine and Medicine Division Chief of Hematology and Oncology at the University of Virginia School of Medicine, Charlottesville, VA. Prof. Williams obtained his medical degree from the University of Cincinnati College of Medicine, Cincinnati, OH, and then became a microbiology specialist, receiving certification from the Harvard University School of Public Health, Boston, MA. Prof. Williams also completed a bachelor’s degree in botany at the Ohio State University, Columbus, OH, before moving to the University of Virginia School of Medicine, Charlottesville, VA, where he completed his residency in internal medicine followed by clinical fellowships in hematology and oncology.
Prof. Williams currently serves as a Scientific Advisor on the boards of the Lymphoma Research Foundation and the European Mantle Cell Lymphoma Network. He is also Vice-Chair of the Eastern Cooperative Group Lymphoma Core Committee.
Novel therapeutics in lymphoma and chronic lymphocytic leukemia
Prof. Williams’s research interests are in novel therapeutic approaches chronic lymphocytic leukemia (CLL) and lymphoma, with a focus in mantle cell lymphoma (MCL). Prof. Williams’ most recent involvement includes a review of the presentation and management of non-nodal MCL and a study investigating multi-drug resistance in CLL.